nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abbreviations and Acronyms
|
|
|
2007 |
|
2S2 |
p. S4-S7 4 p. |
artikel |
2 |
Acknowledgments
|
|
|
2007 |
|
2S2 |
p. S159- 1 p. |
artikel |
3 |
Clinical Challenges in Diagnosis and Management of Diabetic Kidney Disease
|
Stanton, Robert C. |
|
2014 |
|
2S2 |
p. S3-S21 19 p. |
artikel |
4 |
Contents
|
|
|
2007 |
|
2S2 |
p. A3-A4 nvt p. |
artikel |
5 |
Contents
|
|
|
2014 |
|
2S2 |
p. A3- 1 p. |
artikel |
6 |
Disclaimer/Notice page
|
|
|
2007 |
|
2S2 |
p. A5- 1 p. |
artikel |
7 |
Editorial Board
|
|
|
2007 |
|
2S2 |
p. A2- 1 p. |
artikel |
8 |
Figures
|
|
|
2007 |
|
2S2 |
p. S2-S3 2 p. |
artikel |
9 |
Foreword
|
Levin, Adeera |
|
2007 |
|
2S2 |
p. S10-S11 2 p. |
artikel |
10 |
Frontiers in Diabetic Kidney Disease: Introduction
|
Stanton, Robert C. |
|
2014 |
|
2S2 |
p. S1-S2 2 p. |
artikel |
11 |
Glycemic Management in ESRD and Earlier Stages of CKD
|
Williams, Mark E. |
|
2014 |
|
2S2 |
p. S22-S38 17 p. |
artikel |
12 |
KDOQI™ Advisory Board Members
|
|
|
2007 |
|
2S2 |
p. S9- 1 p. |
artikel |
13 |
KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease
|
|
|
2007 |
|
2S2 |
p. S12-S154 143 p. |
artikel |
14 |
Markers of and Risk Factors for the Development and Progression of Diabetic Kidney Disease
|
MacIsaac, Richard J. |
|
2014 |
|
2S2 |
p. S39-S62 24 p. |
artikel |
15 |
Masthead
|
|
|
2007 |
|
2S2 |
p. A1- 1 p. |
artikel |
16 |
Masthead
|
|
|
2014 |
|
2S2 |
p. A1- 1 p. |
artikel |
17 |
New Insights Into Molecular Mechanisms of Diabetic Kidney Disease
|
Badal, Shawn S. |
|
2014 |
|
2S2 |
p. S63-S83 21 p. |
artikel |
18 |
References
|
|
|
2007 |
|
2S2 |
p. S160-S179 20 p. |
artikel |
19 |
Support Page
|
|
|
2014 |
|
2S2 |
p. A2- 1 p. |
artikel |
20 |
Tables
|
|
|
2007 |
|
2S2 |
p. S1-S2 2 p. |
artikel |
21 |
Work group biographies
|
|
|
2007 |
|
2S2 |
p. S155-S158 4 p. |
artikel |
22 |
Work Group Membership
|
|
|
2007 |
|
2S2 |
p. S8- 1 p. |
artikel |